Threshold Pharmaceuticals Inc (THLD.OQ)

THLD.OQ

About

Threshold Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of drugs targeting the microenvironment of solid tumors and the bone marrows of some hematologic malignancies (blood cancers) as treatments for patients living with cancer. The Company's hypoxia activated prodrug product... (more)

Buy/Sell

» Analyst Consensus

Overall

Beta:	1.72
Market Cap (Mil.):	$314.97
Shares Outstanding (Mil.):	56.55
Dividend:	--
Yield (%):	--

Financials

	THLD.OQ	Industry	Sector
P/E (TTM):	20.04	53.78	35.83
EPS (TTM):	0.28	--	--
ROI:	42.76	1.00	18.72
ROE:	--	2.10	19.54

Latest News about THLD.OQ

» More THLD.OQ News

Competitors

	Price	Change
AstraZeneca plc (AZN.L)	3,383.00p	-6.50
Bristol Myers Squibb Co. (BMY.N)	$43.30	+0.53
Bristol Myers Squibb Co. (BMY_p.N)	$567.60	0.00
Eli Lilly & Co. (LLY.N)	$55.90	-0.04
GlaxoSmithKline plc (GSK.L)	1,712.50p	+5.00
Bayer AG (BAYGn.DE)	€83.79	-1.01
Bayer AG (BAYE.F)	--	--
Roche Holding Ltd. (ROG.VX)	CHF247.00	+1.00
Johnson & Johnson (JNJ.N)	$88.09	+0.64
Onyx Pharmaceuticals, Inc. (ONXX.OQ)	$95.65	+0.30

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
THRESHOLD PHARMACEUTICALS INC (THLD) 12-months forecast Provider: Pechala's Reports	$15.00 Buy
Threshold Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
Thomson Reuters Stock Report - THRESHOLD PHARMACEUTICALS, INC. (THLD-O) Provider: Thomson Reuters Stock Report	$25.00 Buy
ValuEngine Detailed Valuation Report for THLD Provider: ValuEngine, Inc.	$127.00 Buy
Wright Investors Service Comprehensive Report for Threshold Pharmaceuticals, Inc. Provider: Wright Reports	$460.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.